Buscar Close Search
Buscar Close Search
Page Menu

RTI Newsroom

Getting Results…
  • Sharing of knowledge, ideas celebrated during Qualifying Exam Recognition Ceremony

    Sharing of knowledge, ideas celebrated during Qualifying Exam Recognition Ceremony

    The UMass Chan community gathered to celebrate 53 PhD candidates and MD/PhD students who transitioned from student to candidate for a doctoral degree during the 2022-2023 academic year.

    Read more
  • NIH funds Kirschstein Award recipient Johan Girgenrath’s fertility research

    NIH funds Kirschstein Award recipient Johan Girgenrath’s fertility research

    PhD candidate John Girgenrath has received a competitive award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development to conduct fertility research.

    Read more
  • UMass Chan’s Water Safe Worcester program promotes swimming safety for city’s teenagers

    UMass Chan’s Water Safe Worcester program promotes swimming safety for city’s teenagers

    Water Safe Worcester’s summer session is underway every Wednesday night through the end of August. The program is free and open to all teenagers in the Worcester area.

    Read more
  • UMass Chan BRIDGE Fund invests nearly $2M in 13 faculty projects

    UMass Chan BRIDGE Fund invests nearly $2M in 13 faculty projects

    The BRIDGE Fund supports critical research milestones for inventions and discoveries that have high potential to change the course of disease and continues to grow, increasing from approximately $1 million per year in 2019 to $3 million in 2024.

    Read more
  • Antisense therapy restores fragile X protein production in human cells

    Antisense therapy restores fragile X protein production in human cells

    An antisense therapy developed by Joel D. Richter, PhD, Sneha Shah, PhD, and Jonathan K. Watts, PhD, at UMass Chan Medical School and Elizabeth Berry-Kravis, MD, PhD, at RUSH University Medical Center, restores production of the protein FMRP in cell samples taken from patients with fragile X syndrome. 

    Read more
  • Carolyn Kraus receives competitive Ruth L. Kirschstein award

    Carolyn Kraus receives competitive Ruth L. Kirschstein award

    PhD candidate Carolyn Kraus has received an award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases to develop a CRISPR/Cas9 tool for designing a safer Duchenne muscular dystrophy therapeutic.

    Read more
  • Clinical study aims to identify early molecular and biological signatures of vitiligo

    Clinical study aims to identify early molecular and biological signatures of vitiligo

    John E. Harris, MD, PhD, and Manuel Garber, PhD, will lead a $3.75 million NIH clinical study at UMass Chan Medical School to identify potential preclinical genetic, molecular and biological signatures that may predispose patients to developing vitiligo.

    Read more
  • UMass Chan, Moderna partner to provide microscopes to Worcester middle schools

    UMass Chan, Moderna partner to provide microscopes to Worcester middle schools

    Dozens of new microscopes will be delivered to six Worcester middle schools thanks to a partnership between UMass Chan Medical School and Moderna.

    Read more
  • MD/PhD student using NIH award to study onset of Huntington’s disease

    MD/PhD student using NIH award to study onset of Huntington’s disease

    MD/PhD student Jillian Belgrad has received an award from the National Institute of Neurological Disorders and Stroke to study the pathology that drives the development of Huntington’s disease symptoms.  

    Read more
  • Terence R. Flotte appears on ‘Giants of Gene Therapy’ podcast

    Terence R. Flotte appears on ‘Giants of Gene Therapy’ podcast

    In a one-on-one interview, Terence R. Flotte shares what inspired him to pursue a career in medicine and what he’s learned in his role as provost and dean of the T.H. Chan School of Medicine at UMass Chan.

    Read more
Showing 1-10 of 64 items
of 7
 wen-xue-card.jpg

RESEARCH NEWS

New nanoparticles can perform gene editing in the lungs

Dr. Wen Xue at the RNA Therapeutics Institute at University of Massachusetts Chan Medical School and Dr. Daniel Anderson at MIT have designed a new type of nanoparticle that can be administered to the lungs, where it can deliver messenger RNA (mRNA) encoding useful proteins. 

Read more

 Watts cardDSC_7764-Edit.jpg

RESEARCH NEWS

Personalized medicine is having its day

From made-to-order genetic therapies to model organisms engineered to be ‘patient avatars’, the technology exists right now to save patients with rare diseases. Jonathan K. Watts, Ph.D., Professor, RTI, UMass Chan Medical School, weighs in on the latest N-of-1 landscape.

Read more

 Watts cardDSC_7764-Edit.jpg

RESEARCH NEWS

EnPlusOne Biosciences Appoints Dr. Jon Watts to Scientific Advisory Board

EnPlusOne Biosciences, Inc., a biotechnology company harnessing the power of enzymes to synthesize RNA oligonucleotides, announced that Jonathan K. Watts, Ph.D., Professor, RTI, UMass Chan Medical School, has been appointed to the company’s Scientific Advisory Board.

Read more

 Craig, Brazil.png

RESEARCH NEWS

Craig Mello visits Instituto de Ciências Biomédicas in Brazil

“The good thing about science? It’s that it takes you places you never thought you’d see.” So goes one of Craig Mello’s sayings, who won the Nobel Prize in Medicine for the discovery of RNA interference along with his colleague Andrew Fire.

Watch Craig's seminar on Informational Therapies: Ancient Mechanisms, New Medicines

 DSC_6932-Mary card.jpg

OUTREACH NEWS

Mary Pickering selected as STEM leader by Aran Nebula Foundation

The Aran Nebula Foundation has selected an inaugural cohort of STEM leaders who have contributed to various STEM fields in extraordinary ways.

Read more about the Foundation

 Craig 10-17-22 CARD.png

RESEARCH NEWS

Craig Mello interviewed at the Bergamo Science Festival

“The good thing about science? It’s that it takes you places you never thought you’d see.” So goes one of Craig Mello’s sayings, who won the Nobel Prize in Medicine for the discovery of RNA interference along with his colleague Andrew Fire.

Watch Craig's interview

 HTT ICV NeuN and CNPase mAb tests.lif_10 nmol Cy3 LNAASO NeuN back-cerebellumSnapshot1.jpg

RESEARCH NEWS

UMass Chan clinical trial shows potential to safely suppress gene related to ALS

Researchers at the UMass Chan Medical School say they have safely used injections to suppress a mutant gene linked to ALS.

Watch WCVB Coverage

 brown-watts-660.png

RESEARCH NEWS

New research from UMass Chan Medical School in Worcester shows ‘encouraging’ results that could slow progression of ALS

New research developed from studies at UMass Chan has the potential to revolutionize treatment options for people with ALS.

Read more from MassLIVE

 IMG_0130.jpg

OUTREACH NEWS

Coloring book created by medical professor addresses vaccine, COVID-19 concerns

A new coloring book is helping kids draw clear lines between COVID-19 and the vaccines. Download or request coloring book.
 
Watch WCVB Channel 5 coverage

 Twitter, rectangle no title.jpg

OUTREACH NEWS

Superhero Emma RNA gives COVID-19 bam! pow! zap! in new comic/coloring book

WORCESTER — There’s a new comic book superhero in town and her mission is combating COVID-19 through education...and coloring. Download or request coloring book.
 
Read more from Worcester T&G

 Spikes Detected1.png

OUTREACH NEWS

UMass Chan Medical School professor creates kids coloring book on COVID-19 vaccine

A new coloring book is helping kids draw clear lines between COVID-19 and the vaccines. Download or request coloring book.
 
Watch Spectrum News coverage

 craig1.jpg

RESEARCH NEWS

First Rounders Podcast: Craig Mello

Craig Mello is a Nobel Laureate, co-founder of Atalanta Therapeutics, and a professor at UMass Chan Medical School, where he runs the Mello Lab. Our conversation covers the lure of conspiracy theorists, the state of RNA therapeutics, and getting that call from the Nobel committee. 

Listen here

 craig-mello.jpg

RESEARCH NEWS

Local Nobel Prize Winner Hopes COVID Vaccine RNA Technology Can Fight Other Diseases

Many experts have hailed the fast development of COVID-19 vaccines as a miracle of modern medicine. The science behind it could pave the way to revolutionary treatments for a number of crippling diseases.

Watch WBZ coverage